Andere talen AroCell AB

Aandelen

Beurs gesloten - Nasdaq Stockholm Andere beurzen 18:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,426 ^SEK	-1,84%		+6,50%	-2,52%

03/05	AroCell AB (publ) rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
22/02	AroCell AB (publ) rapporteert resultaten voor het vierde kwartaal eindigend op 31 december 2023	CI

AroCell : Airlangga University and Dr. Soetomo General Hospital Visit AroCell and IDL offic	19/06
AroCell : Laboratory Engineer	14/06
AroCell AB (publ) Interim Report January 1st to March 31st, 2024	06/05
AroCell Q1 - Unrecognized and going well	06/05
AroCell AB (publ) Interim Report January 1st to March 31st, 2024	03/05
AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05
AroCell - New patent approved on the US market	19/04
Swedish Diagnostics Company AroCell Secures US Patent	18/04
New patent approved on the US market	18/04
AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics	16/04
AroCell publishes the Annual Report for 2023	15/04
AroCell publishes the Annual Report for 2023	12/04
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024	12/03
New Study: UBC Rapid can reduce the number of cystoscopies necessary in bladder cancer patients, enabling cost-effective follow-up	12/03
Two Accepted Abstracts at AACR 2024 Explore Clinical Applications of TK1 Biomarker	11/03
AroCell : Presentation at LabRoots 2024	04/03
AroCell Q4 - Nearing positive operating cash flow	23/02
AroCell AB (publ) Interim Report January 1st to December 31st, 2023	22/02
AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
AroCell AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02

Geen resultaten voor deze zoekopdracht